Parkinson's Disease Drugs Market 2020 Global Top Key Players, Emerging Size, Growth Factor, Share- Novartis, Orion Pharma Ltd, ACADIA Pharmaceuticals Inc.

The global Parkinson's disease drugs market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/parkinson-s-disease-drugs-market-100655

Leading Players operating in the Parkinson's Disease Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Pfizer, Inc.
o F. Hoffmann-La Roche Ltd
o Merck & Co., Inc.
o Novartis
o Orion Pharma Ltd
o UCB S.A
o Teva Pharmaceutical Industries Ltd.
o Vertical Pharmaceuticals, LLC
o ACADIA Pharmaceuticals Inc.
o Impax Laboratories, Inc.
o H. Lundbeck A/S.

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Market Trends
o Key Insights
o Prevalence of Parkinson's Disease - For Key Countreis, 2018
o Regulatory Scenario - For Key Countries
o Patent Snapshot
o New Product Launch
o Pipeline Analysis
o Key Industry Developments - Mergers, Acquisitions and Partnerships
o Global Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Drug Class
? Decarboxylase Inhibitors
? Dopamine Agonists
? Monoamine Oxidase Type B (MAO-B) Inhibitors
? Catechol-O-Methyltransferase (COMT) Inhibitors
? Others
o Market Analysis, Insights and Forecast - By Route of Administration
? Oral
? Injection
? Transdermal
o Market Analysis, Insights and Forecast - By Distribution Channel
? Hospital Pharmacy
? Retail Pharmacy
? Online Stores
o Market Analysis, Insights and Forecast - By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa
o North America Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
o Key Findings / Summary
o Market Analysis - By Drug Class
? Decarboxylase Inhibitors
? Dopamine Agonists
? Monoamine Oxidase Type B (MAO-B) Inhibitors
? Catechol-O-Methyltransferase (COMT) Inhibitors
? Others
o Market Analysis - By Route of Administration
? Oral
? Injection
? Transdermal
o Market Analysis - By Distribution Channel
? Hospital Pharmacy
? Retail Pharmacy
? Online Stores
o Market Analysis - By Country
? U.S.
? Canada

Market Segmentation:

By Drug Class
o Decarboxylase Inhibitors
o Dopamine Agonists
o Monoamine Oxidase Type B (MAO-B) Inhibitor
o Catechol-O-Methyltransferase (COMT) Inhibitors
o Others
By Route of Administration
o Oral
o Injection
o Transdermal
By Distribution Channels
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
By Geography
o North America (USA and Canada)
o Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
o Latin America (Brazil, Mexico and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/parkinson-s-disease-drugs-market-100655

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.